openPR Logo
Press release

Neuromyelitis Optica (Devic's Syndrome) Market Size, Share & Forecast 2025 | Most Leading - Alexion Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, Viela Bio, Genentech, Inc., AstraZeneca, Shanghai Pharmaceutical Group Co., Ltd.

06-12-2025 12:21 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Neuromyelitis Optica (Devic's Syndrome) Market

Neuromyelitis Optica (Devic's Syndrome) Market

The Neuromyelitis Optica (Devic's Syndrome) Market is estimated to reach at a CAGR of 4.8% during the forecast period 2024-2031.

Neuromyelitis Optica Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/neuromyelitis-optica-market?ca

Neuromyelitis Optica (NMO), also known as Devic's Syndrome, is a rare autoimmune disorder that primarily affects the optic nerves and spinal cord, leading to vision loss, muscle weakness, and paralysis. Unlike multiple sclerosis, NMO is often more severe and involves distinct antibodies, particularly anti-AQP4. Early diagnosis and treatment with immunosuppressive therapies are crucial to prevent relapses and minimize long-term neurological damage.

Major players in the Neuromyelitis Optica market

The prominent players in Neuromyelitis Optica market research report are: Alexion Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, Viela Bio, Genentech, Inc., AstraZeneca, Shanghai Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical GroupCo., Ltd. and Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. SAGENT PHARMACEUTICALS, INC. and ZYDUS PHARMACEUTICALS, INC.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Neuromyelitis Optica Market Dynamics

Rising cases of neuromyelitis optica (NMO), an autoimmune disorder affecting the optic nerves and spinal cord, are driving market growth. Recently approved treatments like Soliris, Uplizna, and Enspryng target harmful antibodies linked to NMO. With a global prevalence of 1-10 per 100,000 people, and slightly higher rates in populations of African ancestry, growing awareness and treatment options are supporting market expansion.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/neuromyelitis-optica-market?ca

Neuromyelitis Optica Market Segments

By Product Type: Eculizumab, Methylprednisolone, Azathioprine, Mycophenolate Mofetil, Rituximab

By Application: Hospitals, Clinics, Homecare and Telemedicine

The Neuromyelitis Optica industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Neuromyelitis Optica Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay ahead with data-driven strategies, competitive analysis, and future outlook.

👉 Get the Extensive Full Report Now: https://www.datamintelligence.com/buy-now-page?report=neuromyelitis-optica-market?ca

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromyelitis Optica (Devic's Syndrome) Market Size, Share & Forecast 2025 | Most Leading - Alexion Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, Viela Bio, Genentech, Inc., AstraZeneca, Shanghai Pharmaceutical Group Co., Ltd. here

News-ID: 4063866 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Automatic Packaging Robot Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
United States Automatic Packaging Robot Market 2025 | Industry Developments, Fut …
Automatic Packaging Robot Market reached US$ 4.0 billion in 2023 and is projected to reach US$ 10.2 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Automatic Packaging Robot Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and
Human Augmentation Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Human Augmentation Market 2025 | Industry Developments, Future Growth, Share & I …
The Human Augmentation Market reached US$ 252.6 billion in 2023 and is projected to reach US$ 780.7 billion by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Human Augmentation Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging
Learning Management System (LMS) Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Learning Management System (LMS) Market 2025 | Industry Developments, Future Gro …
Learning Management System (LMS) Market reached US$ 18.7 billion in 2023 and is projected to reach US$ 67.2 billion by 2031, growing at a CAGR of 17.7% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Learning Management System Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,
Team Collaboration Tools Market 2025 | Industry Developments, Future Growth, Share & Industry Insights
Team Collaboration Tools Market 2025 | Industry Developments, Future Growth, Sha …
The Team Collaboration Tools Market reached US$ 23.3 billion in 2023 and is projected to reach US$ 62.8 billion by 2031, growing at a CAGR of 13.5% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Team Collaboration Tools Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,

All 5 Releases


More Releases for Neuromyelitis

Neuromyelitis Optica Market Detailed Industry Report Analysis 2025-2034
Introduction Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder of the central nervous system characterized by severe inflammation of the optic nerves and spinal cord. Patients often experience vision loss, paralysis, sensory impairment, and bladder dysfunction. Once considered a variant of multiple sclerosis (MS), NMO is now recognized as a distinct condition, thanks to advancements in diagnostics such as aquaporin-4 (AQP4) antibody testing. Though rare, NMO can
Neuromyelitis Optica Spectrum Disorder Market
According to a new market research report published by Global Market Estimates, the Global Neuromyelitis Optica Spectrum Disorder Market is projected to grow at a CAGR of 6.2% from 2023 to 2028. F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi (France), Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Zydus Cadila, Boehringer Ingelheim International GmbH., Apotex Inc., and AstraZeneca among others, are some of the key players in the global
Neuromyelitis Optica Drug Market Therapeutic Survey Reviews, Analysis 2025
The report titled “Neuromyelitis Optica Drug Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts. The Neuromyelitis Optica Drug was valued
Top News: Neuromyelitis Optica Spectrum Disorder Market Advancements 2019 - 2027
Neuromyelitis Optica Spectrum Disorder Market: Introduction Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of central nervous system which was previously known as Devic disease or neuromyelitis optica (NMO). It is a rare debilitating and lifelong disease characterized by inflammation in spinal cord and optic nerve. View Report : https://www.transparencymarketresearch.com/neuromyelitis-optica-spectrum-disorder-market.html People with neuromyelitis optica spectrum disorder experience symptoms such as paralysis, muscle weakness, and blindness. Neuromyelitis optica spectrum disorder is most common
Neuromyelitis Optica Therapy Market 2020 Analysis and Research Report 2025
The Neuromyelitis Optica Therapy Market report is a collection of useful information, quantitative and qualitative estimation by industry experts, the contribution from industry connoisseurs and industry accomplices across the value chain. Furthermore, the report also provides the qualitative results of diverse market factors on its geographies and segments. In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and
Global Neuromyelitis Optica Drug Market Research Report 2016
Qyresearchreports include new market research report”Global Neuromyelitis Optica Drug Market Research Report 2016″ to its huge collection of research reports. A new research report on the global Neuromyelitis Optica Drug market offers a 360-degree overview of it. The report discusses the market in significant details and elucidates all aspects of the global Neuromyelitis Optica Drug market likely to impact its growth trajectory in the upcoming years. Major market stimulants and deterrents